PHARMACEUTICAL ALLOPATHIC RAW MATERIAL: Gemcitabine Hydrochloride API, manufactured by Shandong Luoxin Pharmaceutical Group Hengxin Pharmaceutical Co., Ltd. Production capacity 100MT/year with Chinese GMP, DML, ISO & WC certificate.
Chengdu Medi-sourcing International Trade Co., Ltd. is one of the subsidiaries of Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. (Luoxin Pharmaceutical Group), responsible for the export business of all products from Luoxin Group and others agent products.
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. is a healthcare conglomerate that is engaged in pharmaceutical research and development, manufacture, sales, and healthcare service. Established from 1988, Luoxin Pharmaceutical Group has six manufacture sites covering formulations, APIs and Intermediates, Chinese medicine and its extracts and Medical apparatus and instruments products. Benefiting from the layout structure of the whole industry chain, Luoxin Pharmaceutical has a strong development momentum and successfully listed on the A-share market in 2019.
Luoxin Pharmaceutical Group has more than 50 production lines and holds on 300 marketing licenses. The formulation products from three formulation factories of Luoxin Pharmaceutical Group cover tablets, capsules, granules, dry suspension, pellets, sterile powder for Injection, lyophilized powder for injection, small-volume parenterals, large-volume parenterals, aerosols, sprays and prefilled.
){kind=link}